Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
Pain Med
; 15(8): 1365-72, 2014 Aug.
Article
em En
| MEDLINE
| ID: mdl-24666664
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Fentanila
/
Dor Irruptiva
/
Dor Crônica
/
Analgésicos Opioides
/
Transtornos Relacionados ao Uso de Opioides
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article